Location History:
- Llandeilo, GB (1994)
- Dyfed, GB (1995)
- Ffairfach, GB (1999)
Company Filing History:
Years Active: 1994-1999
Title: Christopher Powell-Jones: Innovator in Thrombotic Treatment
Introduction
Christopher Powell-Jones is a notable inventor based in Dyfed, GB. He has made significant contributions to the field of medicine, particularly in the treatment of thrombotic events. With a total of 3 patents to his name, Powell-Jones has developed innovative methods that aim to improve patient outcomes.
Latest Patents
His latest patents include a groundbreaking method for preventing the formation of platelet-rich clots or thrombus. This method utilizes hementin, a polypeptide derived from leech salivary glands, to deaggregate existing platelet-rich clots. Hementin can be administered in a pharmaceutically acceptable carrier or excipient, with or without additional anticoagulants such as hirudin, hirudin analogues, or an inhibitor of factor Xa. This innovative approach has the potential to revolutionize thrombotic treatment.
Career Highlights
Throughout his career, Powell-Jones has worked with reputable companies, including Biopharm (UK) Limited and Merck Patent GmbH. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in medical treatments.
Collaborations
He has collaborated with notable professionals in the field, including Roy T Sawyer and Asgar Electricwala. These partnerships have further enhanced his research and development efforts.
Conclusion
Christopher Powell-Jones is a distinguished inventor whose work in thrombotic treatment showcases his commitment to medical innovation. His contributions are paving the way for new therapeutic options that could greatly benefit patients suffering from thrombotic conditions.